A UCLA researcher has found that one of the most commonly prescribed medications for Alzheimer’s disease may accelerate the cognitive decline of patients who carry a genetic variation. Read more...
Photo: Sophie Sokolow, an associate professor at the UCLA School of Nursing, said Donezepil has been used to treat patients with mild cognitive impairment. (Wesley Hardin/Daily Bruin)






